Promelanogenic Effects by an Annurca Apple-Based Natural Formulation in Human Primary Melanocytes.
melanins
natural bioactive molecules
skin pigmentation
skin pigmenting agents
tyrosinase
Journal
Clinical, cosmetic and investigational dermatology
ISSN: 1178-7015
Titre abrégé: Clin Cosmet Investig Dermatol
Pays: New Zealand
ID NLM: 101543449
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
01
2021
accepted:
25
02
2021
entrez:
1
4
2021
pubmed:
2
4
2021
medline:
2
4
2021
Statut:
epublish
Résumé
Melanocytes are engaged in synthesis, transport, and release of pigments at the epidermal-melanin units in response to the finely regulated melanogenic pathway. A multifaceted combination of both intrinsic and extrinsic factors - from endocrine and paracrine dynamics to exogenous stimuli such as sunlight and xenobiotics - modulates expression and activity of proteins involved in pigmentation, including the rate-limiting enzyme tyrosinase. As well as playing critical physiological functions comprising skin photoprotection, melanins define hair and skin pigmentation which in turn have impacted considerably to human social communication since time immemorial. Additionally, numerous skin diseases based on pigmentation alterations can have serious public influence. While several melanogenesis inhibitors are already available, the number of melanin activators and tyrosinase stimulators as drug-like agents is still limited. To explore the biological effects of an Annurca Apple-based nutraceutical preparation (AMS) on melanin production, experiments in cellular models of human skin were performed. Both primary cultures and co-cultures of epidermal melanocytes (HEMa) and follicular keratinocytes (HHFK) were used. We show that AMS, by now branded for its cutaneous beneficial effects, induces in total biocompatibility a significant promelanogenic effect in human primary melanocytes. In line, we found melanin cytosolic accumulation consistent with tyrosinase up-regulation. Disposal of skin pigmenting agents would be attractive for the treatment of hypopigmentation disorders, to postpone skin photoaging or simply for fashion, so that discovery and development of melanogenesis stimulators, especially from natural sources, is nowadays a dynamic area of research.
Identifiants
pubmed: 33790611
doi: 10.2147/CCID.S299569
pii: 299569
pmc: PMC8008161
doi:
Types de publication
Journal Article
Langues
eng
Pagination
291-301Informations de copyright
© 2021 Ferraro et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest for this work.
Références
Br J Dermatol. 2018 Mar;178(3):632-639
pubmed: 28494100
J Nat Med. 2018 Mar;72(2):563-569
pubmed: 29442220
Nature. 2018 Nov;563(7732):S99
pubmed: 30464284
Biochimie. 2009 Mar;91(3):364-72
pubmed: 19041686
Exp Dermatol. 2008 May;17(5):395-404
pubmed: 18177348
Antioxidants (Basel). 2020 Jul 18;9(7):
pubmed: 32708455
Cold Spring Harb Perspect Med. 2014 May 01;4(5):
pubmed: 24789876
Nutrients. 2018 Oct 02;10(10):
pubmed: 30279339
Pigment Cell Res. 2001 Aug;14(4):236-42
pubmed: 11549105
PLoS One. 2015 Jun 01;10(6):e0128678
pubmed: 26030901
Sci Rep. 2017 Mar 28;7:45236
pubmed: 28349991
Physiol Rev. 2004 Oct;84(4):1155-228
pubmed: 15383650
Pigment Cell Melanoma Res. 2019 Mar;32(2):224-236
pubmed: 30019545
J Cosmet Dermatol. 2019 Jun;18(3):703-727
pubmed: 30866156
Bioorg Med Chem. 2016 Nov 1;24(21):5440-5448
pubmed: 27622747
Dermatol Clin. 2007 Jul;25(3):271-81, vii
pubmed: 17662893
Int J Cosmet Sci. 2018 Aug;40(4):328-347
pubmed: 29752874
Postepy Hig Med Dosw (Online). 2016 Jun 30;70(0):695-708
pubmed: 27356601
Tokai J Exp Clin Med. 2014 Sep 20;39(3):116-21
pubmed: 25248426
Nutrients. 2019 Jan 09;11(1):
pubmed: 30634393
Cancer Res. 1985 Apr;45(4):1474-8
pubmed: 2983883
Br J Dermatol. 2002 Apr;146 Suppl 61:7-10
pubmed: 11966725
J Invest Dermatol. 1999 Mar;112(3):310-6
pubmed: 10084307
Biochim Biophys Acta. 2011 May;1813(5):704-12
pubmed: 21333694
Int J Mol Sci. 2018 Jun 13;19(6):
pubmed: 29899264
Protein Sci. 2015 Sep;24(9):1360-9
pubmed: 26104241
J Investig Dermatol Symp Proc. 1999 Sep;4(1):35-40
pubmed: 10537005
Acc Chem Res. 2010 Nov 16;43(11):1452-60
pubmed: 20734991
Drug Discov Today. 2017 Feb;22(2):282-298
pubmed: 27693716
Pigment Cell Res. 2000 Aug;13(4):222-9
pubmed: 10952389
Molecules. 2017 Aug 04;22(8):
pubmed: 28777326
Annu Rev Genomics Hum Genet. 2019 Aug 31;20:41-72
pubmed: 31100995
Oncol Lett. 2019 May;17(5):4183-4187
pubmed: 30944614
Molecules. 2018 Jul 21;23(7):
pubmed: 30037075
J Med Food. 2017 Mar;20(3):288-300
pubmed: 28296588
Mini Rev Med Chem. 2017;17(9):785-798
pubmed: 28019642
Pigment Cell Melanoma Res. 2009 Dec;22(6):809-18
pubmed: 19659742
Sci Rep. 2019 May 7;9(1):7006
pubmed: 31065032
Physiol Rev. 2019 Jan 1;99(1):1-19
pubmed: 30255724
Int J Mol Sci. 2016 Jul 15;17(7):
pubmed: 27428965
Postepy Dermatol Alergol. 2013 Feb;30(1):30-41
pubmed: 24278043
Biomedicines. 2020 Sep 01;8(9):
pubmed: 32882959
J Med Food. 2018 Jan;21(1):90-103
pubmed: 28956697
Nutrients. 2019 Dec 13;11(12):
pubmed: 31847069
Exp Dermatol. 2009 Sep;18(9):760-3
pubmed: 19558501
Photochem Photobiol. 2018 May;94(3):421-431
pubmed: 28977677